Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To assess the association between diabetes mellitus (DM) and the incidence of cancer at different sites.
Data from the baseline and first three follow-up visits of the Atherosclerosis Risk in Communities (ARIC) study, an ongoing cohort study of adults from four American communities, were used in this study. Of 15,792 persons aged 45–64 years old who participated in the baseline visit, the data of 15,118 participants were available for this study. For each cancer site, a conditional stratified Poisson regression model was fitted to estimate the adjusted relative rate and 95% confidence interval (adj. RR, 95% CI) of its incidence in diabetics compared to non-diabetics.
We excluded 850 participants with a history of cancer at baseline and 149 participants who developed cancer during 2 years after enrollment, leaving a total of 14,119 participants of whom 1721 were diabetics. Independent of age, body mass index, alcohol consumption, and physical activity, DM decreased the risk of all cancers combined (adj. RR: 0.77, 95% CI: 0.60, 0.98) and the risk of prostate cancer (adj. RR: 0.51, 95% CI: 0.27, 0.97) and increased the risk of colorectal cancer in non-menopausal women (adj. RR: 12.08, 95% CI: 2.06, 70.94).
In conclusion, DM may be associated with an increased risk of colorectal cancer in non-menopausal women and a decreased risk of prostate cancer and all cancers combined.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Burden G, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study 2016. JAMA Oncol. 2018;4:1553–68. CrossRef
Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–210. CrossRef
Aric Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objects. Am J Epidemiol. 1989;129:687–702. CrossRef
World HealthOrganization. International statistical classification of disease and related health problems, tenth revision (ICD-10). Geneva: World Health Organization; 1992.
National Cancer Institute (NCI). Risk Factors for Cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk. Accessed 16 Mar 2018.
Miulescu RD, Dănoiu S, Margină D, Păun S, Poiană C. Dynamics of prostate-specific antigen levels during treatment with testosterone undecanoate in patients with type 2 diabetes mellitus. Rom J Diabetes Nutr Metab Dis. 2012;19:397–403.
Luo W, Cao Y, Liao C, Gao F. Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies. Color Dis. 2012;14:1307–12. CrossRef
Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA. Diabetes, abnormal glucose, dyslipidemia, hypertension and risk of inflammatory and other breast cancer. Cancer Epidemiol Biomark Prev. 2017;26:862–8. CrossRef
- Diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study
Mohammad Ali Mansournia
- Springer International Publishing
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II